Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Siemens’ Advia Centaur Syphilis Assay receives CE Mark

Siemens’ Advia Centaur Syphilis Assay receives CE Mark

10th August 2011

Siemens has received CE Mark approval for its new Advia Centaur assay, which is used in the detection of syphilis.

The device has been ratified for sale in Europe, providing users with a new testing tool for a serious condition that accelerates workflows and offers improved efficiency.

According to the manufacturer, the Advia Centaur Syphilis Assay functions by detecting antibodies against Treponema pallidum, a bacteria known to cause the sexually-transmitted disease.

New means of identifying the condition are important due to the serious neurological and cardiovascular complications it can cause, as well as the fact that its symptoms often mimic those of other conditions.

Dave Hickey, chief executive officer for Siemens' chemistry, immunoassay, automation and diagnostics IT business unit, said: "Consolidating syphilis testing onto a single system addresses a critical challenge of laboratories today."

This comes after the firm introduced a new B-type natriuretic peptide assay for its Dimension Vista Intelligent Lab System last month.ADNFCR-8000103-ID-800695532-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.